{
    "organizations": [],
    "uuid": "d4b9a6660c8b3d44a243546e8a200f98c4217277",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-taiwan-liposome-co-ltd-sees-us-ipo/brief-taiwan-liposome-co-ltd-sees-u-s-ipo-of-up-to-35-million-sec-filing-idUSFWN1RT097",
    "ord_in_thread": 0,
    "title": "BRIEF-Taiwan Liposome Co Ltd Sees U.S. IPO Of Up To $35 Million – SEC Filing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 16 (Reuters) - Taiwan Liposome Co Ltd:\n* TAIWAN LIPOSOME CO LTD SEES U.S. IPO OF UP TO $35 MILLION – SEC FILING\n* TAIWAN LIPOSOME CO LTD SAYS ASSUMING IPO PRICE OF $7.46 PER ADS, INITIAL PUBLIC OFFERING WOULD RESULT IN OFFERING OF 4.7 MILLION ADSS Source text: ( bit.ly/2qzSIqH ) Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-04-16T18:31:00.000+03:00",
    "crawled": "2018-04-17T12:22:11.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "taiwan",
        "liposome",
        "co",
        "ltd",
        "taiwan",
        "liposome",
        "co",
        "ltd",
        "see",
        "ipo",
        "million",
        "sec",
        "filing",
        "taiwan",
        "liposome",
        "co",
        "ltd",
        "say",
        "assuming",
        "ipo",
        "price",
        "per",
        "ad",
        "initial",
        "public",
        "offering",
        "would",
        "result",
        "offering",
        "million",
        "adss",
        "source",
        "text",
        "company",
        "coverage"
    ]
}